An earth plant-based compostable biodegradable composition for the formation of a bioplastic and method of producing said resin, the composition comprising: about 17.5 to 45% ethanol-based green polyethylene by weight, about 20 to 25% calcium carbonate by weight, about 2 to 12% hemp hurd or soy protein by weight, about 32 to 45% starch by weight, and about 0.5 to 1% biodegradation additive by weight to enable biodegradation and composting of the bioplastic; wherein the composition is produced by first mill grinding the ethanol-based green polyethylene, calcium carbonate, hemp hurd or soy protein, starch and the biodegradation additive into fine powders, then mechanically mixing the fine powders one by one into a final mixture for about 5-25 minutes at a time, dry and without heat, and then heating the final mixture to about 220 to 430 degrees Fahrenheit.

The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.

The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.

The present invention relates to a filament for 3D printing, comprising (A) at least one semicrystalline polyamide, (B) at least one amorphous polyamide (C) at least one flame retardant of formula (I), wherein R.sup.1 and R.sup.2 are independently of each other a linear or branched C.sub.1-C.sub.8alkyl group, or an optionally substituted aryl group, M represents is an alkali metal ion, an alkaline earth metal ion, an aluminum ion, a zinc ion, an iron ion or a boron ion; m represents 1, 2 or 3; and n represents 1, 2 or 3, a process for the preparation of the filament and its use in a process for preparation of a three-dimensional object, by a fused filament fabrication process.

The present invention relates to a filament for 3D printing, comprising (A) at least one semicrystalline polyamide, (B) at least one amorphous polyamide (C) at least one flame retardant of formula (I), wherein R.sup.1 and R.sup.2 are independently of each other a linear or branched C.sub.1-C.sub.8alkyl group, or an optionally substituted aryl group, M represents is an alkali metal ion, an alkaline earth metal ion, an aluminum ion, a zinc ion, an iron ion or a boron ion; m represents 1, 2 or 3; and n represents 1, 2 or 3, a process for the preparation of the filament and its use in a process for preparation of a three-dimensional object, by a fused filament fabrication process.

The application relates to a method and apparatus for producing a solid foam continuously. A homogeneous suspension is formed from a raw material in which the suspension comprises a solidifying agent, and a foam mixture which comprises bubbles is formed by mixing air bubbles into the suspension. The foam mixture is injected via at least one nozzle to form a foam pattern and the foam pattern is laid on a moving surface and the foam mixture of the foam pattern is solidified in order to form a solid foam such that the bubbles of the foam mixture shrink in off-length directions to form the shaped bubbles. Further, the application relates to the product and the use of the method.

The application relates to a method and apparatus for producing a solid foam continuously. A homogeneous suspension is formed from a raw material in which the suspension comprises a solidifying agent, and a foam mixture which comprises bubbles is formed by mixing air bubbles into the suspension. The foam mixture is injected via at least one nozzle to form a foam pattern and the foam pattern is laid on a moving surface and the foam mixture of the foam pattern is solidified in order to form a solid foam such that the bubbles of the foam mixture shrink in off-length directions to form the shaped bubbles. Further, the application relates to the product and the use of the method.

The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.

The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.

An earth plant-based compostable biodegradable composition for the formation of a bioplastic and method of producing said resin, the composition comprising: about 17.5 to 45% ethanol-based green polyethylene by weight, about 20 to 25% calcium carbonate by weight, about 2 to 12% hemp hurd or soy protein by weight, about 32 to 45% starch by weight, and about 0.5 to 1% biodegradation additive by weight to enable biodegradation and composting of the bioplastic; wherein the composition is produced by first mill grinding the ethanol-based green polyethylene, calcium carbonate, hemp hurd or soy protein, starch and the biodegradation additive into fine powders, then mechanically mixing the fine powders one by one into a final mixture for about 5-25 minutes at a time, dry and without heat, and then heating the final mixture to about 220 to 430 degrees Fahrenheit.